from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3069/-

LFCtreatmentdescriptionclass of inhibitor

0.694

Amikacinug/mL Amikacintranslation

0.446

Cap5-10ug/mL Capreomycintranslation

2.374

Rox10-50 ug/mL Roxithromycintranslation

1.465

SM2-5 ug/mL Streptomycintranslation

0.791

Tet5-10 ug/mL Tetracyclinetranslation

0.387

Rif0.2-5ug/mL Rifampicintranscription

0.676

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.112

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.587

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.078

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.106

Clofazimine10-13 ug/mL Clofaziminerespiration

0.308

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.500

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.076

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.031

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.042

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.357

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.377

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.305

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.479

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.058

KCN5-20 ug/mL Potassium cyaniderespiration

-1.419

NaN30.2-2 mM Sodium aziderespiration

-0.348

Nigericin50 uM Nigericinrespiration

-0.226

TRC10-150 ug/mL Triclosanrespiration

-0.646

TRZ10-25 ug/mL Thioridazinerespiration

0.495

Valinomycin0.5-10 uM Valinomycinrespiration

4.554

ZnSO42 mM ZnSO4respiration

-0.746

menadione6-10 ug/mL Menadionerespiration

-0.272

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.044

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.093

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.506

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.740

NRP_1Non-replicating persistence stage 1dosRassociated

0.047

Amp0.2mg/mL AmpicillincellWall

0.519

Cephalexin20-100 ug/mL CephalexincellWall

0.661

Cerulenin0.32-5 ug/mL CerulenincellWall

0.151

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.349

EMB10-20 ug/mL EthambutolcellWall

0.331

Eta12-40 ug/mL EthionamidecellWall

-0.074

INH0.2-0.4 ug/mL IsoniazidcellWall

0.003

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.696

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.469

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.447

BZA0.12 mg/mL BenzamidearomaticAmides

-0.104

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.056

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.266

H2O24 mM hydrogen peroxideDNAdamaging

0.095

Levo10 ug/mL LevofloxacinDNAdamaging

-0.018

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.360

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.459

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.286

UVUV-irradiationDNAdamaging

0.001

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.244

Antimycin12.5-50 ug/mL Antimycin A?

-0.063

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.804

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.735

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.740

PA8240.2-2 ug/mL PA-824?

0.213

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.553

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.222

Verapamil50 uM Verapamil?

0.008

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.505

methoxatin10-20 ug/mL Methoxatin?